在心血管疾病病理生理学中肌动脉胀发展的机制
Diana G Kiseleva1,2, Tatiana V Kirichenko2,3, Yuliya V Markina2
1Department of Biophysics, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Biomedicines
|February 24, 2024
概括
心肌,心肌中的多余液体,恶化心血管疾病. 了解它的分子和细胞机制可能会揭示新的诊断和治疗目标.
科学领域:
- 心血管科学 心血管科学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 心肌胀是心肌中液体积累,与毛细血管透性,葡萄糖充电和淋巴排水有关.
- 它越来越被认为不仅是一种并发症,而且是心血管疾病严重程度和不良后果的驱动因素.
研究的目的:
- 审查心肌胀发育背后的分子和细胞机制.
- 确定潜在的治疗点来管理心肌胀.
主要方法:
- 在PubMed索引的文章的综合文献综述,截至2024年1月.
- 专注于分子,遗传和机械的变化,在心肌在的过程中.
主要成果:
- 详细描述了导致心肌胀的主要分子和细胞通路.
- 确定影响液体积累和心脏功能障碍的关键因素.
结论:
- 阐明心肌胀机制对于推进心血管疾病治疗至关重要.
- 针对特定的分子和细胞途径为新型疗法提供了有前途的途径.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Cardiac Performance
658
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
658
Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Mechanism of Cardiac Arrhythmias
920
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
920


